By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2910 Seventh Street

Berkeley  California  94710  U.S.A.
Phone: 510-204-7200 or 800-BIO-XOMA
Fax: 510-644-0539



Company News
XOMA (US) LLC (XOMA) Announces Pricing Of $40.0 Million Registered Offering Of Common Stock And Warrants 12/9/2014 10:50:29 AM
XOMA (US) LLC (XOMA) To Present At Upcoming Investor Conferences 11/11/2014 10:06:55 AM
XOMA (US) LLC (XOMA) Initiates Pivotal Phase 3 Gevokizumab Study In Patients With Pyoderma Gangrenosum 11/4/2014 7:23:46 AM
XOMA (US) LLC (XOMA) To Announce Third Quarter 2014 Financial Results And Host Webcast On November 6 10/28/2014 7:01:24 AM
XOMA (US) LLC (XOMA) Launches XOMA 358 Clinical Development 10/9/2014 8:19:37 AM
The Texas A&M University System And XOMA (US) LLC (XOMA) License Innovative Manufacturing Technology 10/7/2014 7:19:53 AM
XOMA (US) LLC (XOMA) Initiates U.S. Clinical Trial Of Gevokizumab In Patients With Behcet's Disease Uveitis - EYEGUARD™-U.S. 10/1/2014 7:47:17 AM
XOMA (US) LLC (XOMA) Highlights Recent Achievements And Reports Financial Results For Second Quarter 2014 8/8/2014 7:51:11 AM
XOMA (US) LLC (XOMA) To Present At Two Upcoming Investor Conferences 8/6/2014 4:32:52 PM
XOMA (US) LLC (XOMA) To Announce Second Quarter 2014 Financial Results And Host Webcast On August 7 7/30/2014 4:05:03 PM